Licensing life-saving drugs for developing countries: evidence from the medicines patent pool
Galasso, A. & Schankerman, M.
(2024).
Licensing life-saving drugs for developing countries: evidence from the medicines patent pool.
The Review of Economics and Statistics,
106(6), 1529 – 1541.
https://doi.org/10.1162/rest_a_01253
(2024).
Licensing life-saving drugs for developing countries: evidence from the medicines patent pool.
The Review of Economics and Statistics,
106(6), 1529 – 1541.
https://doi.org/10.1162/rest_a_01253
We study the effects of the Medicines Patent Pool (MPP)—an institution that pools patents across geographical markets—on the licensing and adoption of life-saving drugs in low- and middle-income countries. We show the presence of an immediate and large increase in licensing when a patent is included in the MPP. We also show evidence that the pool increases actual entry and volume of sales, but these impacts are much smaller than on licensing, which is due to the geographic bundling of licenses. The paper highlights the potential of pools in promoting diffusion of biomedical innovation in developing countries.
Explore Further
- I18 - Government Policy; Regulation; Public Health
- O31 - Innovation and Invention: Processes and Incentives
- O34 - Intellectual Property Rights: National and International Issues
-
Schankerman, M. & Galasso, A.
(2022).
Replication data for: Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool.
[Dataset]. Harvard Dataverse.
https://doi.org/10.7910/dvn/8aapih